Modified R-MINE Regimen vs. R-GemOx Regimens on the Treatment of Late Relapsed DLBCL

NCT07389356 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

70

Enrollment

OTHER

Sponsor class

Conditions

DLBCL - Diffuse Large B Cell Lymphoma

Interventions

DRUG: Rituximab+Ifosfamide+Mesna+Mitoxantrone hydrochloride liposome+Etoposide
DRUG: Rituximab+Gemcitabine+Oxaliplatin

Sponsor

The First Affiliated Hospital with Nanjing Medical University